
1. J Coll Physicians Surg Pak. 2021 Nov;31(11):1372-1374. doi:
10.29271/jcpsp.2021.11.1372.

Impact of COVID-19 Pandemic on Treatment of Pediatric Oncology Patients: Report
from Resource-limited Setting.

Sindhu II(1), Sarfraz S(1), Shaheen N(1), Khan A(1), Saeed H(1).

Author information: 
(1)Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital &
Research Centre, Lahore, Pakistan.

The aim of this study was to determine how the COVID-19 pandemic impacted on the 
effective management; and the outcome of pediatric oncology patients in Shaukat
Khanum Memorial Cancer Hospital & Research Centre, Lahore. Data was
retrospectively reviewed from 15 March to 15 June 2020 after the approval of
Institutional Review Board Committee. A total of 258 patients on active oncology 
treatment between the study period were included. The total number of patients
whose treatment was affected were 118 (45.7%), while 140 (54.3%) patients
received treatment in time. There was total 34 (13.2%) patients relapsed, 23
(67.6%) patients in which treatment delayed, and 11 (32.4%) patients in which
their treatment not delayed; while, n=218 (84.5%) were in remission, and 6 (2.3%)
patients absconded. COVID-19 pandemic caused a sudden impediment in the treatment
of pediatric oncology patients, and is likely to affect the long-term survival
outcome of pediatric oncology patients. Key Words: Chemotherapy, Radiotherapy,
Surgery, Long term outcome.

DOI: 10.29271/jcpsp.2021.11.1372 
PMID: 34689503  [Indexed for MEDLINE]

